Insulin Action, Diabetogenes, and the Cause of Type II Diabetes

The person who passes urine which is exceedingly sweet, cool, slightly viscid, turbid, and resembling the juices of the sugarcane … suffers from glycosuria. … There are two types of urinary disorders—one, natural due to genetic factors, and the other due to indiscreet living or dietetic indiscretions. The patient suffering from the former is thin, pale, eats less and drinks too much.… The patient with the latter is usually obese, eats a lot, is stout, of sedentary habits and sleeps too much.

[1]  R. Roth,et al.  Identification of SHC as a substrate of the insulin receptor kinase distinct from the GAP-associated 62 kDa tyrosine phosphoprotein. , 1993, Biochemical and biophysical research communications.

[2]  H. Tornqvist,et al.  Mutation of arginine 86 to proline in the insulin receptor alpha subunit causes lack of transport of the receptor to the plasma membrane, loss of binding affinity and a constitutively activated tyrosine kinase in transfected cells. , 1993, Biochemical and biophysical research communications.

[3]  B V Howard,et al.  Impaired glucose tolerance as a disorder of insulin action. Longitudinal and cross-sectional studies in Pima Indians. , 1988, The New England journal of medicine.

[4]  P. H. Seeburg,et al.  Human insulin receptor and its relationship to the tyrosine kinase family of oncogenes , 1985, Nature.

[5]  C. Kahn,et al.  Insulin induces rapid accumulation of insulin receptors and increases tyrosine kinase activity in the nucleus of cultured adipocytes , 1993, Journal of cellular physiology.

[6]  B. Rn,et al.  Lilly lecture 1989. Toward physiological understanding of glucose tolerance. Minimal-model approach. , 1989 .

[7]  C. Kahn,et al.  Insulin rapidly stimulates tyrosine phosphorylation of a Mr-185,000 protein in intact cells , 1985, Nature.

[8]  C. Kahn,et al.  Tryptic activation of the insulin receptor. Proteolytic truncation of the alpha-subunit releases the beta-subunit from inhibitory control. , 1988, The Journal of biological chemistry.

[9]  J. Exton.  Signaling through phosphatidylcholine breakdown. , 1990, The Journal of biological chemistry.

[10]  A. Hattersley,et al.  Linkage of type 2 diabetes to the glucokinase gene , 1992, The Lancet.

[11]  J. A. Scarlett,et al.  Receptor and postreceptor defects contribute to the insulin resistance in noninsulin-dependent diabetes mellitus. , 1981, The Journal of clinical investigation.

[12]  A. Kosaki,et al.  Insulin-resistant diabetes due to a point mutation that prevents insulin proreceptor processing. , 1988, Science.

[13]  H. Tager.  Abnormal Products of the Human Insulin Gene , 1984, Diabetes.

[14]  G. Rubin,et al.  Sevenless, a cell-specific homeotic gene of Drosophila, encodes a putative transmembrane receptor with a tyrosine kinase domain. , 1987, Science.

[15]  M. White,et al.  The New Elements of Insulin Signaling: Insulin Receptor Substrate-1 and Proteins With SH2 Domains , 1993, Diabetes.

[16]  R. Medema,et al.  Ras activation by insulin and epidermal growth factor through enhanced exchange of guanine nucleotides on p21ras , 1993, Molecular and cellular biology.

[17]  S. Harrison,et al.  Recognition of a high-affinity phosphotyrosyl peptide by the Src homology-2 domain of p56lck , 1993, Nature.

[18]  C. Kahn,et al.  Demonstration of a primary (? genetic) defect in insulin receptors in fibroblasts from a patient with the syndrome of insulin resistance and acanthosis nigricans type A. , 1980, The Journal of clinical endocrinology and metabolism.

[19]  O. Rosen.  After insulin binds. , 1987, Science.

[20]  L. Cantley,et al.  Activation of phosphatidylinositol 3-kinase by insulin. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[21]  M. White,et al.  YMXM motifs of IRS-1 define substrate specificity of the insulin receptor kinase. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[22]  P. Cuatrecasas.  Insulin--receptor interactions in adipose tissue cells: direct measurement and properties. , 1971, Proceedings of the National Academy of Sciences of the United States of America.

[23]  W. Fantl,et al.  Signalling by receptor tyrosine kinases. , 1993, Annual review of biochemistry.

[24]  N. Tonks,et al.  Insulin activates the kinase activity of the Raf-1 proto-oncogene by increasing its serine phosphorylation. , 1990, The Journal of biological chemistry.

[25]  C. Kahn.  Insulin resistance, insulin insensitivity, and insulin unresponsiveness: a necessary distinction. , 1978, Metabolism: clinical and experimental.

[26]  T. Pawson,et al.  SH2 domains recognize specific phosphopeptide sequences , 1993, Cell.

[27]  C. Kahn,et al.  The insulin signaling system. , 1994, The Journal of biological chemistry.

[28]  G. Reaven.  Role of Insulin Resistance in Human Disease , 1988, Diabetes.

[29]  H. Tager.  Lilly lecture 1983. Abnormal products of the human insulin gene. , 1984, Diabetes.

[30]  A. Ullrich,et al.  Human insulin receptors mutated at the ATP-binding site lack protein tyrosine kinase activity and fail to mediate postreceptor effects of insulin. , 1987, The Journal of biological chemistry.

[31]  J. Massagué,et al.  Electrophoretic resolution of three major insulin receptor structures with unique subunit stoichiometries. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[32]  M. Permutt.  Use of DNA polymorphisms for genetic analysis of non-insulin dependent diabetes mellitus. , 1991, Bailliere's clinical endocrinology and metabolism.

[33]  J. Riordan,et al.  Identification of the Cystic Fibrosis Gene : Chromosome Walking and Jumping Author ( s ) : , 2008 .

[34]  R. Roth,et al.  Insulin receptor: evidence that it is a protein kinase. , 1983, Science.

[35]  G. Bell,et al.  Prevalence of insulin-gene mutations in non-insulin-dependent diabetes mellitus. , 1986, The New England journal of medicine.

[36]  B. Rosner,et al.  Familial Clustering of Insulin Sensitivity , 1992, Diabetes.

[37]  A. Ullrich,et al.  Mutation of the insulin receptor at tyrosine 960 inhibits signal transmission but does not affect its tyrosine kinase activity , 1988, Cell.

[38]  J. Avruch,et al.  Kinetic properties of the insulin receptor tyrosine protein kinase: activation through an insulin-stimulated tyrosine-specific, intramolecular autophosphorylation. , 1986, Archives of biochemistry and biophysics.

[39]  R. DeFronzo,et al.  Pathogenesis of NIDDM: A Balanced Overview , 1992, Diabetes Care.

[40]  R. Birge,et al.  Closing in on SH2 specificity. , 1993, Science.

[41]  T. Olson,et al.  Post-translational changes in tertiary and quaternary structure of the insulin proreceptor. Correlation with acquisition of function. , 1988, The Journal of biological chemistry.

[42]  D. Leroith,et al.  Insulin and insulin-like growth factor-I stimulate a common endogenous phosphoprotein substrate (pp185) in intact neuroblastoma cells. , 1987, The Journal of biological chemistry.

[43]  W. Rutter,et al.  Replacement of insulin receptor tyrosine residues 1162 and 1163 compromises insulin-stimulated kinase activity and uptake of 2-deoxyglucose , 1986, Cell.

[44]  W. Rutter,et al.  The cysteine-rich domains of the insulin and insulin-like growth factor I receptors are primary determinants of hormone binding specificity. Evidence from receptor chimeras. , 1990, The Journal of biological chemistry.

[45]  J. Larner,et al.  Insulin-like effect of trypsin on the phosphorylation of rat adipocyte insulin receptor. , 1983, The Journal of biological chemistry.

[46]  S. O’Rahilly,et al.  Detection of Mutations in Insulin-Receptor Gene in NIDDM Patients by Analysis of Single-Stranded Conformation Polymorphisms , 1991, Diabetes.

[47]  I. Macara,et al.  The ras superfamily of molecular switches. , 1991, Cellular signalling.

[48]  G F Cahill,et al.  Starvation in man. , 1970, The New England journal of medicine.

[49]  C. Kahn,et al.  Phorbol ester-induced serine phosphorylation of the insulin receptor decreases its tyrosine kinase activity. , 1988, The Journal of biological chemistry.

[50]  al. et,et al.  Human diabetes associated with a mutation in the tyrosine kinase domain of the insulin receptor. , 1989, Science.

[51]  J. Roth,et al.  Defect in insulin binding to receptors in obese man. Amelioration with calorie restriction. , 1975, The Journal of clinical investigation.

[52]  K. Jarnagin,et al.  The human insulin receptor cDNA: The structural basis for hormone-activated transmembrane signalling , 1985, Cell.

[53]  T. Kadowaki,et al.  Normal insulin receptor substrate-1 phosphorylation in autophosphorylation-defective truncated insulin receptor. Evidence that phosphorylation of substrates might be sufficient for certain biological effects evoked by insulin. , 1993, The Journal of biological chemistry.

[54]  J. Schlessinger,et al.  How receptor tyrosine kinases activate Ras. , 1993, Trends in biochemical sciences.

[55]  T. Pawson,et al.  The insulin receptor substrate 1 associates with the SH2-containing phosphotyrosine phosphatase Syp. , 1993, The Journal of biological chemistry.

[56]  R. B. Kerr,et al.  Insulin-sensitive and insulin-insensitive types of diabetes mellitus. , 1939 .

[57]  M J Saad,et al.  Regulation of insulin receptor substrate-1 in liver and muscle of animal models of insulin resistance. , 1992, The Journal of clinical investigation.

[58]  C. Kahn,et al.  Insulin stimulates serine and tyrosine phosphorylation in the juxtamembrane region of the insulin receptor. , 1993, The Journal of biological chemistry.

[59]  R. Bergman,et al.  Modeling of insulin action in vivo. , 1992, Annual review of physiology.

[60]  W. Rutter,et al.  A membrane-anchored cytoplasmic domain of the human insulin receptor mediates a constitutively elevated insulin-independent uptake of 2-deoxyglucose. , 1987, Molecular endocrinology.

[61]  R. Cerione,et al.  The Ras superfamilies: regulatory proteins and post-translational modifications. , 1991, Current opinion in cell biology.

[62]  J. Silverman,et al.  Studies on the mechanism of insulin resistance in the liver from humans with noninsulin-dependent diabetes. Insulin action and binding in isolated hepatocytes, insulin receptor structure, and kinase activity. , 1986, The Journal of clinical investigation.

[63]  C. Kahn,et al.  Differences in the sites of phosphorylation of the insulin receptor in vivo and in vitro. , 1985, The Journal of biological chemistry.

[64]  R. Taylor,et al.  Abnormal Activation of Glycogen Synthesis in Fibroblasts from NIDDM Subjects: Evidence for an Abnormality Specific to Glucose Metabolism , 1993, Diabetes.

[65]  C. Kahn,et al.  7 The Insulin Receptor and Tyrosine Phosphorylation , 1986 .

[66]  J. Blenis,et al.  Dissociation of pp70 ribosomal protein S6 kinase from insulin-stimulated glucose transport in 3T3-L1 adipocytes. , 1993, Journal of Biological Chemistry.

[67]  T. Pawson,et al.  SH2 and SH3 domains: From structure to function , 1992, Cell.

[68]  D. Accili,et al.  Mutations in Insulin-Receptor Gene in Insulin-Resistant Patients , 1990, Diabetes Care.

[69]  H. King,et al.  The epidemiology and natural history of NIDDM--lessons from the South Pacific. , 1990, Diabetes/metabolism reviews.

[70]  A. Ullrich,et al.  Characterization of an endogenous substrate of the insulin receptor in cultured cells. , 1987, The Journal of biological chemistry.

[71]  Nanxin Li,et al.  Guanine-nucleotide-releasing factor hSos1 binds to Grb2 and links receptor tyrosine kinases to Ras signalling , 1993, Nature.

[72]  E. Krebs,et al.  Microtubule-associated protein 2 kinases, ERK1 and ERK2, undergo autophosphorylation on both tyrosine and threonine residues: implications for their mechanism of activation. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[73]  C. Yip.  The insulin‐binding domain of insulin receptor is encoded by exon 2 and exon 3 , 1992, Journal of cellular biochemistry.

[74]  Jerrold,et al.  Insulin resistance and diabetes due to different mutations in the tyrosine kinase domain of both insulin receptor gene alleles. , 1991, The Journal of biological chemistry.

[75]  J. Olefsky.  Lilly Lecture 1980: Insulin Resistance and Insulin Action: An In Vitro and In Vivo Perspective , 1981, Diabetes.

[76]  C. Kahn,et al.  Insulin stimulates tyrosine phosphorylation of the insulin receptor in a cell-free system , 1982, Nature.

[77]  D. Steiner,et al.  Lessons Learned From Molecular Biology of Insulin-Gene Mutations , 1990, Diabetes Care.

[78]  R. Davis,et al.  Insulin receptor kinase and its mode of signaling membrane components. , 1985, Diabetes/metabolism reviews.

[79]  A. Cherniack,et al.  Binding of the Ras activator son of sevenless to insulin receptor substrate-1 signaling complexes. , 1993, Science.

[80]  H. Lodish,et al.  Cloning of a Rab3 isotype predominantly expressed in adipocytes. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[81]  G. Rubin,et al.  A putative Ras GTPase activating protein acts as a negative regulator of signaling by the Sevenless receptor tyrosine kinase , 1992, Cell.

[82]  Nanxin Li,et al.  The function of GRB2 in linking the insulin receptor to Ras signaling pathways. , 1993, Science.

[83]  J. Lord,et al.  Effect of age on hepatocyte and soleus muscle insulin receptor binding in lean and genetically obese diabetic (ob/ob) mice. , 1985, Diabetes research.

[84]  F. Giorgino,et al.  Glucocorticoid regulation of insulin receptor and substrate IRS-1 tyrosine phosphorylation in rat skeletal muscle in vivo. , 1993, The Journal of clinical investigation.

[85]  T. Pawson,et al.  The SH2 and SH3 domains of mammalian Grb2 couple the EGF receptor to the Ras activator mSos1 , 1993, Nature.

[86]  G. Dohm,et al.  Insulin receptor kinase in human skeletal muscle from obese subjects with and without noninsulin dependent diabetes. , 1987, The Journal of clinical investigation.

[87]  T. Pawson,et al.  The association of insulin-elicited phosphotyrosine proteins with src homology 2 domains. , 1992, The Journal of biological chemistry.

[88]  G. Cooper,et al.  Hydrolysis of phosphatidylcholine couples Ras to activation of Raf protein kinase during mitogenic signal transduction , 1993, Molecular and cellular biology.

[89]  S. Lillioja,et al.  Exaggerated early insulin release and insulin resistance in a diabetes-prone population: a metabolic comparison of Pima Indians and Caucasians. , 1991, The Journal of clinical endocrinology and metabolism.

[90]  O. Rosen,et al.  Autophosphorylation of the insulin receptor in vitro. Designation of phosphorylation sites and correlation with receptor kinase activation. , 1986, The Journal of biological chemistry.

[91]  M. Kasuga,et al.  Substrate specificities of tyrosine-specific protein kinases toward cytoskeletal proteins in vitro. , 1986, The Journal of biological chemistry.

[92]  C. Kahn,et al.  Insulin stimulation of phosphatidylinositol 3-kinase activity maps to insulin receptor regions required for endogenous substrate phosphorylation. , 1992, The Journal of biological chemistry.

[93]  M. Czech,et al.  Insulin-sensitive phosphorylation of serine 1293/1294 on the human insulin receptor by a tightly associated serine kinase. , 1990, The Journal of biological chemistry.

[94]  S. Kottaridis,et al.  Subtraction hybridization cDNA libraries from colon carcinoma and hepatic cancer. , 1990, Genetic analysis, techniques and applications.

[95]  C. Kahn,et al.  Modulation of insulin receptor, insulin receptor substrate-1, and phosphatidylinositol 3-kinase in liver and muscle of dexamethasone-treated rats. , 1993, The Journal of clinical investigation.

[96]  M. G. Carlson,et al.  Impact of Obesity on Insulin Action in NIDDM , 1993, Diabetes.

[97]  S. Elledge,et al.  Normal and oncogenic p21ras proteins bind to the amino-terminal regulatory domain of c-Raf-1 , 1993, Nature.

[98]  J. Olefsky,et al.  Insulin-Receptor Autophosphorylation and Endogenous Substrate Phosphorylation in Human Adipocytes From Control, Obese, and NIDDM Subjects , 1990, Diabetes.

[99]  J. Flier,et al.  Lilly Lecture: Syndromes of Insulin Resistance: From Patient to Gene and Back Again , 1992, Diabetes.

[100]  C. Strader,et al.  Potentiation of specific association of insulin with HepG2 cells by phorbol esters. , 1986, The Biochemical journal.

[101]  F. McCormick.  Signal transduction. How receptors turn Ras on. , 1993, Nature.

[102]  Jonathan A. Cooper,et al.  Autophosphorylation of the PDGF receptor in the kinase insert region regulates interactions with cell proteins , 1989, Cell.

[103]  J. L. Bos,et al.  Two dominant inhibitory mutants of p21ras interfere with insulin-induced gene expression , 1991, Molecular and cellular biology.

[104]  C. Kahn,et al.  Alterations in insulin receptor autophosphorylation in insulin resistance: correlation with altered sensitivity to glucose transport and antilipolysis to insulin. , 1988, The Journal of clinical endocrinology and metabolism.

[105]  C. Kahn,et al.  Phosphorylation of glycolytic and gluconeogenic enzymes by the insulin receptor kinase , 1987, Journal of cellular biochemistry.

[106]  J. Castaño.  Regulation of gene expression by insulin. , 1991, Advances in Enzyme Regulation.

[107]  R. DeFronzo,et al.  The metabolic profile of NIDDM is fully established in glucose-tolerant offspring of two Mexican-American NIDDM parents. , 1992, Diabetes.

[108]  C. Kahn,et al.  Insulin stimulates phosphorylation of c-Jun, c-Fos, and Fos-related proteins in cultured adipocytes. , 1994, The Journal of biological chemistry.

[109]  Y. Yazaki,et al.  Detection of mutations in the human insulin gene by single strand conformation polymorphisms. , 1992, The Journal of clinical endocrinology and metabolism.

[110]  D. Seminara,et al.  Identification of pp120, an endogenous substrate for the hepatocyte insulin receptor tyrosine kinase, as an integral membrane glycoprotein of the bile canalicular domain. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[111]  Nancy Y. Ip,et al.  ERKs: A family of protein-serine/threonine kinases that are activated and tyrosine phosphorylated in response to insulin and NGF , 1991, Cell.

[112]  C. Kahn,et al.  Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein , 1991, Nature.

[113]  N J Cox,et al.  Gene for non-insulin-dependent diabetes mellitus (maturity-onset diabetes of the young subtype) is linked to DNA polymorphism on human chromosome 20q. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[114]  R. Bergman.  Toward Physiological Understanding of Glucose Tolerance: Minimal-Model Approach , 1989, Diabetes.

[115]  J. Avruch,et al.  Identification of insulin receptor tyrosine residues autophosphorylated in vitro. , 1987, The Journal of biological chemistry.

[116]  J. Flier,et al.  A naturally occurring mutation of insulin receptor alanine 1134 impairs tyrosine kinase function and is associated with dominantly inherited insulin resistance. , 1990, The Journal of biological chemistry.

[117]  P. De Meyts.  The diabetogenes concept of NIDDM. , 1993, Advances in experimental medicine and biology.

[118]  J. Olefsky,et al.  Reversibility of defective adipocyte insulin receptor kinase activity in non-insulin-dependent diabetes mellitus. Effect of weight loss. , 1988, The Journal of clinical investigation.

[119]  J. Olefsky,et al.  Insulin Binding, Internalization, and Insulin Receptor Regulation in Fibroblasts from Type II, Non-insulin-dependent Diabetic Subjects , 1981, Diabetes.

[120]  A. Krolewski,et al.  Slow glucose removal rate and hyperinsulinemia precede the development of type II diabetes in the offspring of diabetic parents. , 1990, Annals of internal medicine.

[121]  Simeon I. Taylor,et al.  Two mutant alleles of the insulin receptor gene in a patient with extreme insulin resistance. , 1988, Science.

[122]  L. Elsas,et al.  Activation of glucose transport by a natural mutation in the human insulin receptor. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[123]  M. Czech,et al.  Complex regulation of simple sugar transport in insulin-responsive cells. , 1992, Trends in biochemical sciences.

[124]  S. Giannini,et al.  The role of COOH-terminal and acidic domains in the activity and stability of human insulin receptor protein tyrosine kinase studied by purified deletion mutants of the beta subunit domain. , 1993, The Journal of biological chemistry.

[125]  A. Ullrich,et al.  A mutation in the extracellular domain of the insulin receptor impairs the ability of insulin to stimulate receptor autophosphorylation. , 1991, The Journal of biological chemistry.

[126]  Y. Yazaki,et al.  Site-directed mutagenesis of the juxtamembrane domain of the human insulin receptor. , 1993, The Journal of biological chemistry.

[127]  E. Van Obberghen,et al.  The insulin receptor activation process involves localized conformational changes. , 1992, The Journal of biological chemistry.

[128]  T. Sturgill,et al.  Biochemical characterization of a family of serine/threonine protein kinases regulated by tyrosine and serine/threonine phosphorylations. , 1991, The Journal of biological chemistry.

[129]  C. Yip,et al.  Mutation of the high cysteine region of the human insulin receptor alpha-subunit increases insulin receptor binding affinity and transmembrane signaling. , 1989, The Journal of biological chemistry.

[130]  C. Kahn,et al.  Insulin stimulates the phosphorylation of the 95,000-dalton subunit of its own receptor. , 1982, Science.

[131]  B. Margolis,et al.  Phosphatidylinositol 3′‐kinase is activated by association with IRS‐1 during insulin stimulation. , 1992, The EMBO journal.

[132]  Y. Ebina,et al.  Insulin-stimulated GLUT4 translocation is relevant to the phosphorylation of IRS-1 and the activity of PI3-kinase. , 1993, Biochemical and biophysical research communications.

[133]  J. Olefsky,et al.  Mutation of the two carboxyl-terminal tyrosines results in an insulin receptor with normal metabolic signaling but enhanced mitogenic signaling properties. , 1991, The Journal of biological chemistry.

[134]  L. Orci,et al.  Reduced beta-cell glucose transporter in new onset diabetic BB rats. , 1990, The Journal of clinical investigation.

[135]  K. Siddle,et al.  The insulin receptor functions normally in Chinese hamster ovary cells after truncation of the C terminus. , 1991, The Journal of biological chemistry.

[136]  C. Kahn,et al.  Insulin receptor substrate 1 mediates insulin and insulin-like growth factor I-stimulated maturation of Xenopus oocytes. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[137]  C. Kahn,et al.  The structure of insulin receptor and its subunits. Evidence for multiple nonreduced forms and a 210,000 possible proreceptor. , 1982, The Journal of biological chemistry.

[138]  C. Kahn,et al.  Cell culture studies on patients with extreme insulin resistance. I. Receptor defects on cultured fibroblasts. , 1982, The Journal of clinical endocrinology and metabolism.

[139]  C. Kahn,et al.  Regulation of phosphatidylinositol 3-kinase activity in liver and muscle of animal models of insulin-resistant and insulin-deficient diabetes mellitus. , 1993, The Journal of clinical investigation.

[140]  J. Tavaré,et al.  Characterization of insulin-stimulated protein serine/threonine kinases in CHO cells expressing human insulin receptors with point and deletion mutations. , 1992, The Biochemical journal.

[141]  N. Møłler,et al.  Identification of determinants that confer ligand specificity on the insulin receptor. , 1992, The Journal of biological chemistry.

[142]  C. Kahn,et al.  Insulin receptor deficiency in genetic and acquired obesity. , 1975, The Journal of clinical investigation.

[143]  J. Parsons,et al.  pp125FAK a structurally distinctive protein-tyrosine kinase associated with focal adhesions. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[144]  C. Kahn,et al.  Characterization of Binding and Phosphorylation Defects of Erythrocyte Insulin Receptors in the Type A Syndrome of Insulin Resistance , 1986, Diabetes.

[145]  D. Lindhout,et al.  An Arg for Gly substitution at position 31 in the insulin receptor, linked to insulin resistance, inhibits receptor processing and transport. , 1992, The Journal of biological chemistry.

[146]  A. Ullrich,et al.  Properties of a human insulin receptor with a COOH-terminal truncation. II. Truncated receptors have normal kinase activity but are defective in signaling metabolic effects. , 1988, The Journal of biological chemistry.

[147]  S. Lillioja,et al.  Normal Coding Sequence of Insulin Gene in Pima Indians and Nauruans, Two Groups With Highest Prevalence of Type II Diabetes , 1991, Diabetes.

[148]  P. Arner,et al.  Insulin receptor binding and metabolic effects of insulin in human subcutaneous adipose tissue in untreated non-insulin dependent diabetes mellitus. , 1987, Upsala journal of medical sciences.

[149]  J. Flier,et al.  Prevalence of Mutations in the Insulin Receptor Gene in Subjects With Features of the Type A Syndrome of Insulin Resistance , 1994, Diabetes.

[150]  W. Möller,et al.  A leucine to proline mutation at position 233 in the insulin receptor inhibits cleavage of the proreceptor and transport to the cell surface. , 1991, Biochemistry.

[151]  O. Pedersen,et al.  Insulin Receptor Binding to Fat and Blood Cells and Insulin Action in Fat Cells from Insulin-dependent Diabetics , 1982, Diabetes.

[152]  E. Cerasi.  Insulin resistance, insulin deficiency, and non-insulin-dependent diabetes mellitus. , 1991, Diabetes research and clinical practice.

[153]  Y. Zick,et al.  The insulinomimetic agents H2O2 and vanadate stimulate protein tyrosine phosphorylation in intact cells. , 1990, The Journal of biological chemistry.

[154]  K. Siddle,et al.  Analysis of insulin-receptor phosphorylation sites in intact cells by two-dimensional phosphopeptide mapping. , 1988, The Biochemical journal.

[155]  R. Ballotti,et al.  Insulin receptor tyrosine kinase is defective in skeletal muscle of insulin-resistant obese mice , 1985, Nature.

[156]  I. Goldfine,et al.  Monoclonal antibodies mimic insulin activation of ribosomal protein S6 kinase without activation of insulin receptor tyrosine kinase. Studies in cells transfected with normal and mutant human insulin receptors. , 1989, The Journal of biological chemistry.

[157]  R. Roth,et al.  Substrates and signalling complexes: The tortured path to insulin action , 1992, Journal of cellular biochemistry.

[158]  C. Kahn,et al.  Human Skeletal Muscle Insulin Receptor Substrate-1: Characterization of the cDNA, Gene, and Chromosomal Localization , 1993, Diabetes.

[159]  E. Van Obberghen,et al.  Insulin and okadaic acid induce Rab4 redistribution in adipocytes. , 1993, The Journal of biological chemistry.

[160]  C. Kahn,et al.  Cloning of the mouse insulin receptor substrate-1 (IRS-1) gene and complete sequence of mouse IRS-1. , 1994, Biochimica et biophysica acta.

[161]  R. Weinberg,et al.  Association of Sos Ras exchange protein with Grb2 is implicated in tyrosine kinase signal transduction and transformation , 1993, Nature.

[162]  M. White,et al.  Pleiotropic insulin signals are engaged by multisite phosphorylation of IRS-1 , 1993, Molecular and cellular biology.

[163]  C. Kahn,et al.  Insulin receptor kinase domain autophosphorylation regulates receptor enzymatic function. , 1992, The Journal of biological chemistry.

[164]  M. White,et al.  IRS-1: essential for insulin- and IL-4-stimulated mitogenesis in hematopoietic cells. , 1993, Science.

[165]  W. Rutter,et al.  Endogenous substrates of the insulin receptor: studies with cells expressing wild-type and mutant receptors. , 1991, Advances in experimental medicine and biology.

[166]  A. Porras,et al.  The ras signaling pathway mimics insulin action on glucose transporter translocation. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[167]  A. Kissebah,et al.  Relation of body fat distribution to metabolic complications of obesity. , 1982, The Journal of clinical endocrinology and metabolism.

[168]  C. Kahn,et al.  Rad: a member of the Ras family overexpressed in muscle of type II diabetic humans. , 1993, Science.

[169]  C. Kahn,et al.  Conformational changes in the alpha- and beta-subunits of the insulin receptor identified by anti-peptide antibodies. , 1989, The Journal of biological chemistry.

[170]  R. N. Bergman,et al.  Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up study , 1992, The Lancet.

[171]  J. Beckmann,et al.  Familial hyperglycemia due to mutations in glucokinase. Definition of a subtype of diabetes mellitus. , 1993, The New England journal of medicine.

[172]  A. Ullrich,et al.  Altered expression of insulin receptor types A and B in the skeletal muscle of non-insulin-dependent diabetes mellitus patients. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[173]  W. Gottschalk.  The pathway mediating insulin's effects on pyruvate dehydrogenase bypasses the insulin receptor tyrosine kinase. , 1991, The Journal of biological chemistry.

[174]  C. Kahn,et al.  Insulin induces the phosphorylation of nucleolin. A possible mechanism of insulin-induced RNA efflux from nuclei. , 1993, The Journal of biological chemistry.

[175]  I. Goldfine,et al.  Evidence that insulin plus ATP may induce a conformational change in the beta subunit of the insulin receptor without inducing receptor autophosphorylation. , 1991, The Journal of biological chemistry.

[176]  A. Munnich,et al.  Maternally inherited duplication of the mitochondrial genome in a syndrome of proximal tubulopathy, diabetes mellitus, and cerebellar ataxia. , 1992, American journal of human genetics.

[177]  E. Ravussin,et al.  Distribution of In Vivo Insulin Action in Pima Indians as Mixture of Three Normal Distributions , 1989, Diabetes.

[178]  M. White,et al.  A defective intramolecular autoactivation cascade may cause the reduced kinase activity of the skeletal muscle insulin receptor from patients with non-insulin-dependent diabetes mellitus. , 1989, The Journal of biological chemistry.

[179]  A. Brunetti,et al.  Transmembrane signalling by insulin via an insulin receptor mutated at tyrosines 1158, 1162, and 1163. , 1991, Biochemical and biophysical research communications.

[180]  A. Hattersley,et al.  Type II diabetes: search for primary defects. , 1992, Annals of medicine.

[181]  C. Kahn,et al.  Insulin induces the phosphorylation of DNA-binding nuclear proteins including lamins in 3T3-F442A. , 1992, Biochemistry.

[182]  D. Porte.  β-cells in type II diabetes mellitus , 1991, Diabetes.

[183]  M. Stoffel,et al.  Nonsense mutation in the glucokinase gene causes early-onset non-insulin-dependent diabetes mellitus , 1992, Nature.

[184]  R. Turner.  The role of obesity in diabetes. , 1992, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity.

[185]  L. J. Korn,et al.  Ras p21 as a potential mediator of insulin action in Xenopus oocytes. , 1987, Science.

[186]  J. Olefsky,et al.  Analysis of the gene sequences of the insulin receptor and the insulin-sensitive glucose transporter (GLUT-4) in patients with common-type non-insulin-dependent diabetes mellitus. , 1991, The Journal of clinical investigation.

[187]  T Pawson,et al.  SH2 and SH3 domains: elements that control interactions of cytoplasmic signaling proteins. , 1991, Science.

[188]  P. Taberner,et al.  Reduced insulin binding to liver plasma membranes in inherently obese diabetic CBA/Ca mice. , 1991, Biochemical pharmacology.

[189]  J. Maller,et al.  Insulin-stimulated MAP-2 kinase phosphorylates and activates ribosomal protein S6 kinase II , 1988, Nature.

[190]  D. Koshland,et al.  Protein kinase C directly phosphorylates the insulin receptor in vitro and reduces its protein-tyrosine kinase activity. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[191]  J. Wands,et al.  Cloning and increased expression of an insulin receptor substrate-1-like gene in human hepatocellular carcinoma. , 1992, Biochemical and biophysical research communications.

[192]  R G Shulman,et al.  Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin-dependent diabetes by 13C nuclear magnetic resonance spectroscopy. , 1990, The New England journal of medicine.

[193]  Simeon I. Taylor,et al.  Lilly Lecture: Molecular Mechanisms of Insulin Resistance: Lessons From Patients With Mutations in the Insulin-Receptor Gene , 1992, Diabetes.

[194]  C. Kahn,et al.  Insulin-stimulated oocyte maturation requires insulin receptor substrate 1 and interaction with the SH2 domains of phosphatidylinositol 3-kinase , 1993, Molecular and cellular biology.

[195]  H. Maegawa,et al.  Impaired Autophosphorylation of Insulin Receptors From Abdominal Skeletal Muscles in Nonobese Subjects With NIDDM , 1991, Diabetes.

[196]  W. Rutter,et al.  Replacement of lysine residue 1030 in the putative ATP-binding region of the insulin receptor abolishes insulin- and antibody-stimulated glucose uptake and receptor kinase activity. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[197]  P. Arner,et al.  Studies of the human liver insulin receptor in noninsulin-dependent diabetes mellitus. , 1986, The Journal of clinical investigation.

[198]  A Valencia,et al.  The ras protein family: evolutionary tree and role of conserved amino acids. , 1991, Biochemistry.

[199]  J Roth,et al.  Insulin receptors in the liver: specific binding of ( 125 I)insulin to the plasma membrane and its relation to insulin bioactivity. , 1971, Proceedings of the National Academy of Sciences of the United States of America.